SBI Securities »

Maplight Therapeutics shares owned by SBI Securities

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by SBI Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $11k 607 17.57

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Apple (AAPL)
Tesla Motors (TSLA)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Vanguard Total World Stock ETF Etf (VT)
Alphabet Inc Class A cs (GOOGL)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Vanguard High Dividend Yield ETF Etf (VYM)
ST SPDR Portfolio S&P500HighDividend ETF Etf (SPYD)
Alphabet Inc Class C cs (GOOG)
SPDR Gold MiniShares Trust Etf (GLDM)

View all positions for SBI Securities

Top funds holding Maplight Therapeutics

Novo A/S
Fcpm Iii Services B.v.
T. Rowe Price Investment Management
Goldman Sachs Group
BlackRock
Nan Fung Group Holdings
5AM Venture Management
Sanofi
Vanguard Group
Pivotal bioVenture Partners Investment Advisor
Perceptive Advisors
Velan Capital Investment Management
Siren
Geode Capital Management
Vestal Point Capital

View all funds holding Maplight Therapeutics